---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-24-000119"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2024-10-17T23:59:59+00:00"
generated_at: "2026-05-30T13:02:21.822344+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Elevance Health Q3 adjusted EPS $8.37; FY2024 guidance cut to ~$33.00

## Summary
- Q3 2024 operating revenue $44.7B, up $2.2B YoY; diluted EPS $4.36 GAAP, adjusted $8.37.
- Benefit expense ratio 89.5%, up 270 bps driven by Medicaid rate-acuity mismatch; operating margin 3.1% (adj 5.3%).
- Medical membership ~45.8M, down 1.5M (3%) due to Medicaid attrition and footprint adjustments.
- Board authorized $8.0B increase to share repurchase program; Q4 dividend $1.63/share declared.
- FY2024 GAAP EPS guidance ~$26.50, adjusted EPS ~$33.00, reflecting Medicaid headwinds.

## SEC filing metadata
- accession: 0001156039-24-000119
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2024-10-17T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603924000119/0001156039-24-000119-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603924000119/elv-20241017.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-24-000119
- JSON: https://secwatch.observer/filing/0001156039-24-000119.json
- Plain text: https://secwatch.observer/filing/0001156039-24-000119.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.